Agenda
9:00 AM — 12:45 PM
Regulatory Affairs: Part 1: The IND – Investigational New Drug Application12:45 PM — 1:30 PM
1:30 PM — 5:30 PM
Regulatory Affairs: Part 2: IND Amendments12:05 PM — 12:50 PM
9:00 AM — 12:00 PM
Regulatory Affairs: Part 5: The NDA – New Drug Application12:00 PM — 12:45 PM
12:45 PM — 5:30 PM
Regulatory Affairs: Part 6: Interactions with FDA9:00 AM — 12:15 PM
Regulatory Affairs: Part 7: Mock FDA Meeting12:15 PM — 1:00 PM
1:00 PM — 4:15 PM
Regulatory Affairs: Part 8: Post-NDA Submission and Approval9:00 AM — 12:30 PM
Regulatory Affairs: Part 9: Labeling, Promotion and Regulatory Intelligence12:30 PM — 1:15 PM
Have an account?
Related events
Face-to-Face
Jun 16, 2024 – Jun 20, 2024
Join us at the premier life sciences conference, celebrating our 60th anniversary! Discover 180+ sessions on Cell and Gene Therapy, Decentralized Clinical Trials, AI, ICH, and more. Get ready to tackle challenges, improve skills, network, and drive change for healthcare at DIA2024.
| Member Early Bird: | Member In-Person Price | Non-Member In-Person Price | |
|---|---|---|---|
| Virtual Event Price | $1,969.00 | $2,245.00 | $2,705.00 |
Online
Register for this On-demand Training Course training course to learn about FDA's approach to regulation of combination products, the processes to streamline development of single entity, and aligning requirements between drugs and devices.
| Member Price | Non-Member Price | |
|---|---|---|
| Virtual Event Price | $1,400.00 | $1,725.00 |
Online
Review the CMC sections of regulatory submissions, the FDA inspection process, and how to avoid or minimize 483s (noncompliance) with this on-demand course.
| Member Price | Non-Member Price | |
|---|---|---|
| Virtual Event Price | $1,800.00 | $2,125.00 |
Online
Complete this On-Demand Training Course to learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.
| Member Price | Non-Member Price | |
|---|---|---|
| Virtual Event Price | $3,545.00 | $3,870.00 |